Ca & Mn dual-ion hybrid nanostimulator boosting anti-tumor immunity via ferroptosis and innate immunity awakening

Limited by low tumor immunogenicity and the immunosuppressive tumor microenvironment (TME), triple-negative breast Cancer (TNBC) has been poorly responsive to immunotherapy so far. Herein, a CA & Mn dual-ion hybrid nanostimulator (CMS) is constructed to enhance anti-tumor immunity through Ferroptosis inducing and innate immunity awakening, which can serve as a Ferroptosis inducer and immunoadjuvant for TNBC concurrently. On one hand, glutathione (GSH) depletion and Reactive Oxygen Species (ROS) generation can be achieved due to the mixed valence state of Mn in CMS. On the Other hand, as an exotic CA²⁺ supplier, CMS causes mitochondrial CA²⁺ overload, which further amplifies the oxidative stress. Significantly, tumor cells undergo Ferroptosis because of the inactivation of Glutathione Peroxidase 4 (GPX4) and accumulation of lipid peroxidation (LPO). More impressively, CMS can act as an immunoadjuvant to awaken innate immunity by alleviating intra-tumor hypoxia and Mn²⁺-induced activation of the STING signaling pathway, which promotes polarization of tumor-associated macrophages (TAMs) and activation of dendritic cells (DCs) for antigen presentation and subsequent infiltration of tumor-specific cytotoxic T lymphocytes (CTLs) into tumor tissues. Taken together, this work demonstrates a novel strategy of simultaneously inducing Ferroptosis and awakening innate immunity, offering a new perspective for effective tumor immunotherapy of TNBC.